LeMaitre Vascular (LMAT) to Release Quarterly Earnings on Thursday

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) is projected to post its quarterly earnings results after the market closes on Thursday, February 27th. Analysts expect LeMaitre Vascular to post earnings of $0.49 per share and revenue of $55.99 million for the quarter. Parties that are interested in registering for the company's conference call can do so using this link.

LeMaitre Vascular Trading Down 1.6 %

Shares of NASDAQ LMAT traded down $1.64 during midday trading on Friday, reaching $99.29. The company's stock had a trading volume of 58,066 shares, compared to its average volume of 155,932. LeMaitre Vascular has a one year low of $59.87 and a one year high of $109.58. The company has a 50 day moving average price of $96.05 and a 200 day moving average price of $93.97. The company has a market cap of $2.23 billion, a price-to-earnings ratio of 54.25, a price-to-earnings-growth ratio of 2.27 and a beta of 0.96.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Wells Fargo & Company initiated coverage on shares of LeMaitre Vascular in a research note on Thursday, February 13th. They issued an "equal weight" rating and a $95.00 price objective for the company. Oppenheimer reaffirmed an "outperform" rating and issued a $93.00 target price (up previously from $90.00) on shares of LeMaitre Vascular in a report on Friday, November 1st. StockNews.com lowered shares of LeMaitre Vascular from a "buy" rating to a "hold" rating in a report on Friday, December 13th. Finally, Barrington Research raised their target price on shares of LeMaitre Vascular from $92.00 to $93.00 and gave the company an "outperform" rating in a research note on Friday, November 1st. Three investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $94.63.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.